About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITING

SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom

NCT06504511•NHS Greater Glasgow and Clyde

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

SCN1ADravet SyndromeEpilepsy

Locations

1

United Kingdom

Locations (1)

Royal Hospital for Children

Glasgow, United Kingdom

Key Dates

Start Date

November 20, 2023

Primary Completion Date

June 1, 2026

Completion Date

June 1, 2026

Last Updated

July 16, 2024

Related Studies

RECRUITINGPhase 1

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

NCT02531880

The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy

NCT06097195

RECRUITINGPhase 3

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

NCT06872125

Dravet Syndrome

RECRUITINGPhase 3

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT06315322

Childhood Absence EpilepsyJuvenile Absence Epilepsy

RECRUITINGPhase 1/2

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

NCT06388707

Drug Resistant EpilepsyEpilepsy+3 more

RECRUITINGPhase 3

Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

NCT07505004

View all related studies

Contacts

Kirsty Hendry, PhD

CONTACT

0141 451 5888 SCN1AHorizons@glasgow.ac.uk

Andreas Brunklaus, MD PhD

CONTACT

0141 451 5888 andreas.brunklaus@glasgow.ac.uk

Sponsors

Lead Sponsor

NHS Greater Glasgow and Clyde

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 16, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions